Tapeworms of the genus Anoplocephala, particularly Anoplocephala perfoliata, represent one of the most clinically significant parasitic infections in horses due to their association with serious and potentially fatal colic syndromes. Unlike the round nematode parasites that comprise most equine worm infections, tapeworms are flat, segmented cestodes that attach at specific sites in the gastrointestinal tract, most commonly the ileocecal junction where the small intestine joins the cecum. This site-specific attachment causes localized damage and inflammation that predisposes horses to various forms of intestinal dysfunction.
Tapeworm infections occur worldwide in grazing horse populations, with prevalence varying by geographic region, pasture management, and diagnostic methods employed. Studies utilizing sensitive diagnostic techniques have demonstrated infection rates ranging from 20 to over 80 percent in different horse populations. The parasites require an intermediate host to complete their life cycle, specifically oribatid mites that live in pasture soil and vegetation, meaning that horses acquire infection exclusively through grazing rather than direct horse-to-horse transmission.
The clinical impact of tapeworm infection ranges from subclinical infection causing no apparent disease to severe, life-threatening colic requiring emergency surgery. Research has definitively linked Anoplocephala perfoliata infection to increased risk of ileal impaction, spasmodic colic, and ileocecal intussusception. Heavy tapeworm burdens at the ileocecal junction cause ulceration, thickening, and dysfunction of this critical anatomical area where intestinal contents transition between digestive regions. Even relatively light infections may contribute to recurrent, low-grade colic episodes.
The good news is that tapeworm infections respond well to treatment with appropriate anthelmintic medications, though drug selection differs from protocols used for nematode parasites. Praziquantel, either alone or in combination products with ivermectin or moxidectin, provides reliable efficacy against equine tapeworms. Strategic treatment, typically administered once or twice yearly, effectively reduces tapeworm burdens and associated colic risk. Recognition of the link between tapeworms and colic has led to increased attention to tapeworm control in comprehensive equine parasite management programs.
